000880:KRXHanwha Corporation Analysis
Data as of 2026-03-07 - not real-time
₩132,600.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hanwha Corporation (000880.KS) is trading well above its 20‑, 50‑ and 200‑day SMAs (124k, 111k and 91k respectively), confirming a bullish price trend. The RSI sits at 56.7, indicating neutral‑to‑slightly bullish momentum, while the MACD histogram is negative (MACD line below signal), suggesting short‑term bearish pressure. The stock’s forward P/E of 7.95 is dramatically lower than the industry average of 29.37, and the DCF‑derived fair value of roughly 632k KRW implies a ~10% upside from the current price of 132.6k KRW. Revenue is expanding at a robust 45.6% YoY, but margins remain thin (gross 14.2%, operating 7.6%, profit 1.7%) and the balance sheet is heavily leveraged with a debt‑to‑equity ratio of 133.
Despite the high leverage, the company holds ample cash (≈63T KRW) and pays a modest dividend (0.83% yield, 5.9% payout), supporting dividend sustainability. Volatility is elevated at 91% over the past 30 days, yet beta is low (~0.68), indicating limited systematic risk. Volume is trending higher, reinforcing the bullish bias, while no material news items currently shift the outlook.
Despite the high leverage, the company holds ample cash (≈63T KRW) and pays a modest dividend (0.83% yield, 5.9% payout), supporting dividend sustainability. Volatility is elevated at 91% over the past 30 days, yet beta is low (~0.68), indicating limited systematic risk. Volume is trending higher, reinforcing the bullish bias, while no material news items currently shift the outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- MACD histogram negative indicating short‑term bearish pressure
- Price already above key moving averages providing support
- Elevated 30‑day volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth (45.6% YoY)
- Significant valuation discount vs industry (forward P/E 7.95 vs 29.37)
- Increasing trading volume supporting bullish trend
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued DCF fair value suggesting upside potential
- Low dividend payout ratio and ample cash buffer
- Diversified conglomerate structure reducing single‑segment exposure
Key Metrics & Analysis
Financial Health
Revenue Growth45.60%
Profit Margin1.74%
P/E Ratio7.9
ROE8.91%
ROA1.21%
Debt/Equity133.08
Op. Cash Flow₩9598.8B
Free Cash Flow₩1434.6B
Industry P/E29.4
Technical Analysis
TrendBullish
RSI56.7
Support₩107,000.00
Resistance₩148,500.00
MA 20₩124,425.00
MA 50₩110,554.00
MA 200₩91,375.00
MACDBearish
VolumeIncreasing
Fear & Greed Index68.77
Valuation
Fair Value₩632,496.11
Target Price₩146,400.00
Upside/Downside10.41%
GradeUndervalued
TypeBlend
Dividend Yield0.83%
Risk Assessment
Beta0.68
Volatility91.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.